Belarus introduces two-tier system

Since the beginning of 2024, Belarus has implemented a two-tier system for drug market authorization. Despite the country's full transition to the Eurasian Economic Union (EAEU) common rules, Belarus has retained the right to apply its own national procedure for certain categories of medicines. This process has been simplified and accelerated, enabling faster access to new medications on the market. More details about the features of the new system can be found in the full story.

Context

Belarus, within the framework of the EAEU, regulates drug authorization alongside common union rules.